Co-Investigator(Kenkyū-buntansha) |
山近 英樹 岡山大学, 大学病院, 講師 (10294422)
滝川 正春 岡山大学, 医歯薬学総合研究科, 教授 (20112063)
森谷 徳文 岡山大学, 医歯薬学総合研究科, 助教 (60467751)
久保田 聡 岡山大学, 医歯薬学総合研究科, 教授 (90221936)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
1) We tried to clarify the regulatory mechanism of CCN2 / CTGF gene expression of tacrolimus in vitro using molecular biological methods, but we could not obtain the expected results. 2) When stimulating HCS-2/8 cells with tacrolimus, analyze exhaustively as well as other variable genes such as dexamethasone, using the microarray method at the time and concentration where CCN2 / CTGF gene expression regulation is the most active Although it was scheduled to do, it could not be achieved due to delay in planning progress.
|